This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Stocks Drop as U.S. Challenges Syria's Chemical Attack

Stocks in this article: ^DJI^GSPC^IXICAMGNONXXTMSAMXBTUCHRW

NEW YORK ( TheStreet) -- Major U.S. stock markets sharply dropped after Secretary of State John Kerry said there was "undeniable" evidence that Syria had used chemical weapons, leaving investors to wonder whether the U.S. will take overt military action to unseat the Assad regime.

The S&P 500 lost 0.4% to 1,656.78. The Dow Jones Industrial Average dropped 0.43% to 14,946.46. The Nasdaq slipped 0.01% to 3,657.57.

"I think any confirmation on use of chemical weapons would obviously be a potential for some kind of action," said Alan Gayle, senior strategist at RidgeWorth Investments. "The market hadn't sold off hard or anything, it's just gone back."

COMEX gold for the December futures contract during electronic trading was jumping $8.90 to $1,402, a critical technical trading level, following comments by Kerry.

Durable goods orders declined sharply by 7.3% in July, the Commerce Department reported Monday before the market open. It was the largest drop since August 2012, snapping three straight months of gains. Economists on average were expecting a decline of 4%.

Amgen (AMGN) was the top gainer in the S&P, surging 7.7% to $113.75 after the world's largest biotechnology company by sales reached a deal to buy cancer drugmaker Onyx Pharmaceuticals (ONXX) for about $10.4 billion in cash. Amgen will acquire Onyx for $125 a share; the deal is expected to be completed at the beginning of the fourth quarter. Onyx Pharmaceuticals was jumping more than 5% as well to $123.51.

TMS International (TMS) surged 12.3% to $17.48 after the provider of procurement and other services to steel mills agreed to sell itself for about $1 billion, including debt, to an investment firm run by Tom Pritzker, a member of one of America's wealthiest business families, people familiar with the matter told The Wall Street Journal.

America Movil SAB de CV (AMX) tacked on 1.5% to $19.73. Spain's Telefonica SA on Monday increased its agreed offer for E-Plus, the German cellular division of Royal KPN NV, to win the backing of major KPN shareholder America Movil SAB de CV.

But America Movil, Mexican billionaire Carlos Slim's group, which said it now owns 29.77% of KPN, reiterated it still plans to go ahead with its proposed €7.2 billion ($9.65 billion) bid in cash for the remaining shares in the Dutch group, Reuters reported.

Peabody Energy ( BTU ) was another top gainer, advancing 2.2% to $18.25 after Barron's wrote that the coal producer's shares may be poised for upside on stronger coal prices as utilities begin moving back to coal from natural gas.

C.H. Robinson Worldwide ( CHRW ) meanwhile added 2.9% to $58.83 after analysts at Deutsche Bank maintained a "buy" view on shares of the logistics company and said that its announcement to increase its share repurchase initiative by 15 million shares will have a strong impact on the stock price and squeeze shorts.

The benchmark 10-year Treasury was rising 7/32, diluting the yield to 2.789%.

-- Written by Andrea Tse and Joe Deaux in New York

>To contact the writer of this article, click here: Andrea Tse.>

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,390.52 +195.10 1.13%
S&P 500 2,018.05 -2.75 -0.14%
NASDAQ 4,630.7410 +64.6030 1.41%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs